National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
74.70
+0.91 (1.23%)
At close: Mar 28, 2025, 4:00 PM
74.00
-0.70 (-0.94%)
After-hours: Mar 28, 2025, 8:00 PM EDT
National Health Investors Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for National Health Investors stock have an average target of 82.2, with a low estimate of 69 and a high estimate of 92. The average target predicts an increase of 10.04% from the current stock price of 74.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for National Health Investors stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 4 | 4 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 8 | 8 | 8 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $70 → $76 | Hold | Maintains | $70 → $76 | +1.74% | Mar 19, 2025 |
| Wedbush | Wedbush | Buy Reiterates $88 | Buy | Reiterates | $88 | +17.80% | Mar 17, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $78 → $72 | Hold | Maintains | $78 → $72 | -3.61% | Dec 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Initiates $81 → $86 | Buy → Hold | Initiates | $81 → $86 | +15.13% | Oct 1, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $92 | Strong Buy | Initiates | $92 | +23.16% | Sep 24, 2024 |
Financial Forecast
Revenue This Year
371.06M
from 335.58M
Increased by 10.57%
Revenue Next Year
430.81M
from 371.06M
Increased by 16.10%
EPS This Year
3.16
from 3.13
Increased by 1.00%
EPS Next Year
3.34
from 3.16
Increased by 5.75%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 460.3M | 561.4M | 647.9M | ||
| Avg | 371.1M | 430.8M | 623.3M | ||
| Low | 329.5M | 349.7M | 604.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.2% | 51.3% | 50.4% | ||
| Avg | 10.6% | 16.1% | 44.7% | ||
| Low | -1.8% | -5.8% | 40.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.42 | 3.61 | 3.50 |
| Avg | 3.16 | 3.34 | 3.36 |
| Low | 2.99 | 3.13 | 3.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.4% | 14.3% | 4.6% |
| Avg | 1.0% | 5.8% | 0.6% |
| Low | -4.5% | -1.1% | -2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.